Rajagopal, S., & Ray, G. (2017). Carbapenem vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts by Propensity Score. Open Forum Infect Dis.
Styl cytowania ChicagoRajagopal, Sumanth, i G.Thomas Ray. "Carbapenem Vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts By Propensity Score." Open Forum Infect Dis 2017.
Styl cytowania MLARajagopal, Sumanth, i G.Thomas Ray. "Carbapenem Vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts By Propensity Score." Open Forum Infect Dis 2017.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..